Dopamine has been shown to inhibit tumor angiogenesis and impede the invasion and migration of GC by suppressing VEGFR-2 phosphorylation and the EGFR/AKT/MMP-13 signaling pathway [29]. Here, AKT1 is linked to neoplasm.